16 results
·
23ms
·
Sources: EU EUDAMED, US FDA
Filters
Regulation: Us FDA
×
aprevo® anterior and lateral lumbar interbody fusion device; aprevo® anterior lumbar interbody fusion devices with interfixation; aprevo® transforaminal lumbar interbody fusion device
FDA 510(k)
FDA Class 2
·Orthopedic
NA
FDA UDI
MEDTRONIC PS MEDICAL, INC.·00613994965882·SHUNT 24133-2 CSF-DELTA CHMBR PERIT 2.0
NA
FDA UDI
MEDTRONIC PS MEDICAL, INC.·00643169483934·SHUNT 24133-2 CSF-DELTA CHMBR PERIT 2.0
BIOGX SARS-COV-2 OPEN SYSTEM REAGENTS FOR BD MAX¿ SYSTEM
FDA Adverse Event
Malfunction
·BECTON, DICKINSON & CO. (SPARKS)·Product code QJR·August 26, 2021
JOEY CLAMP OPENING TOOL
FDA 510(k)
FDA Class 2
·Obstetrics/Gynecology
Captiva Spine SmartLOX Cervical Plate System
FDA 510(k)
FDA Class 2
·Orthopedic
PIN LINER CONST NEUT 50ODX28ID
FDA Adverse Event
Injury
·DEPUY ORTHOPAEDICS·Product code KWZ·April 11, 2013
UNKNOWN INFUSION PUMP
FDA Adverse Event
Injury
·MEDTRONIC NEUROMODULATION·Product code LKK·November 10, 2014
CSE6L SMALLBORE EXTENSION SET
FDA Adverse Event
Malfunction
·B. BRAUN MEDICAL, INC.·Product code KGZ·September 2, 2011
SECURE II MED/SURG BED
FDA Adverse Event
Malfunction
·STRYKER MEDICAL-KALAMAZOO·Product code FNL·July 22, 2013
BELLATEK HYBRID BAR 4 IMPLANTS
FDA Adverse Event
Malfunction
·BIOMET 3I·Product code NHA·December 26, 2024
BELLATEK HYBRID BAR 4 IMPLANTS
FDA Adverse Event
Malfunction
·BIOMET 3I·Product code NHA·January 6, 2025
BELLATEK¿ HYBRID BAR 5 IMPLANTS
FDA Adverse Event
Malfunction
·BIOMET 3I·Product code NHA·February 18, 2025
BELLATEK HYBRID BAR 5 IMPLANTS
FDA Adverse Event
Malfunction
·BIOMET 3I·Product code NHA·March 18, 2025
BELLATEK HYBRID BAR 4 IMPLANTS
FDA Adverse Event
Malfunction
·BIOMET 3I·Product code NHA·January 6, 2025
Boston Scientific TELIGEN, Implantable Cardiac Defibrillator models E102, E110, the following models are not available in the US: models E103, E111, F102, F103, F110, F111. Sterilized using ethylene oxide. Product Usage: This family of implantable cardioverter defibrillators (ICDs) provide a variety of therapies including: -Ventricular tachyarrhythmia therapy, which is used to treat rhythms associated with sudden cardiac death such as VT and VF; -Bradycardia pacing, including adaptive rate pacing, to detect and treat bradyarrhythmias and to provide cardiac rate support after defibrillation therapy. Boston Scientific implantable cardioverter defibrillators (ICDs) are indicated to provide ventricular antitachycardia pacing (ATP) and ventricular defibrillation for automated treatment of life-threatening ventricular arrhythmias
FDA Enforcement
Class II
·Terminated·Boston Scientific CRM Corp·October 29, 2014